Praxis Precision Medicines, Inc.
PRAX Nasdaq
SEC CIK 1689548
Follow Praxis Precision Medicines
Weekly email: filings, results
Net income
−$94.2M
−27.5% vs same quarter last year
EPS, diluted
−$3.23
+3.9% vs same quarter last year
Operating cash flow
−$81.7M
−25.6% vs same quarter last year
Operating income
−$106.9M
−36.4% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $0 | −$303M |
| FY24 | $8.6M | −$183M |
| FY23 | $2.4M | −$123M |
| FY22 | $0 | −$214M |
| FY21 | - | −$167M |
| FY20 | - | −$61.8M |
| FY19 | - | −$35.5M |
| FY18 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$249.1M |
| FY24 | −$131.8M |
| FY23 | −$111.2M |
| FY22 | −$185.5M |
| FY21 | −$125.6M |
| FY20 | −$52.6M |
| FY19 | −$33.5M |
| FY18 | - |